Preclinical and Clinical Amelioration of Bone Fractures with Mesenchymal Stromal Cells: a Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Even though reunion of bone fracture confronts clinicians, mesenchymal stromal cells (MSCs) are investigated to be curative in bone fracture. This study aimed to explore the application potential of MSCs for healing bone fractures. By inputting search terms and retrieving studies published up to March 2021, multiple databases, including PubMed, EMBASE, Web of Science, and Cochrane Library, were searched to identify eligible studies. The mean difference (MD) and 95% confidence interval (95% CI) were calculated to analyze the main results in the meta-analysis. Data analysis was performed using Engauge Digitizer 10.8 and R Software. Of the 31 articles, 26 were preclinical studies ( n = 913), and 5 were clinical trials ( n = 335). Preclinically, MSCs therapy significantly augmented the progress of bone regeneration [(bone volume over tissue volume (MD7.35, p < 0.01)], despite some non-significant effects (on the callus index, bone strength, work to failure, and stiffness). Clinically, the MSC group had a significantly reduced incidence of poor recovery (odds ratio (OR) 0.30, p < 0.01); however, a significant decrease in healing time was not observed in the MSC group (MD 2.47, p = 0.26). In summary, our data suggest that patients with bone fractures benefited from MSC administration and that MSCs are a potentially useful agent for bone regeneration. Despite these satisfactory outcomes, larger randomised clinical trials (RCTs) are necessary to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The available clinical studies on the amelioration of fracture-healing by MSCs in patients (not specifically focusing on healing acceleration) were summarized in a systematic review and meta-analysis by Yi et al. (95), which revealed no decrease in healing time in the MSC group.”
From Methods to accelerate fracture healing – a narrative review from a clinical perspective (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Self-citationWang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
SYRCLE’s risk of bias tool for animal studies
Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-43 · Cited by 4,415
Fracture healing: mechanisms and interventions
Einhorn, T. A., & Gerstenfeld, L. C. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.164 · Cited by 1,807
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0023-5 · Cited by 1,223
Self-citationTGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1979 · Cited by 1,165
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Anasetti, C., Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203517 · Cited by 920
Research works printed but not linked: 4
- Saiz AJ Gionet-Gonzales MA Lee MA Leach JK. Conditioning of myoblast secretome using mesenchymal stem/stromal cell spheroids improves bone repair. Bone. 2019; 125: 151– 159. 31102712 PMC6589400 · DOI
- Zhiguo Q Shufeng M Guojun F. Clinical study on treatment of bone nonunion with MSCs derived from human umblical cord. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009; 23(3): 345– 347. 19366151
- Bradley C Harrison J. Descriptive Epidemiology of T raumatic Fractures in Australia. AIHW; 2004: 88– 96.
- Einhorn TA Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2014; 11(1): 45– 54. 25266456 PMC4464690 · DOI · Paper page
Cited by
Theodosaki, A. M., Tzemi, M., Galanis, N., Bakopoulou, A., Kotsiomiti, E., Aggelidou, E., & Κritis, A. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10696-5 · Cited by 46
“Although the study assesses the administration of stem cells alone, their application seems to be effective in the treatment of bone fractures [27].”
BackgroundMethods to accelerate fracture healing – a narrative review from a clinical perspective
Ganse, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384783 · Cited by 33
Han, S., Li, T., Cao, Y., Li, Z., Mai, Y., Fan, T., Zeng, M., Wen, X., Han, W., Lin, L., et al. (2024) · British Journal of Sports Medicine · doi:10.1136/bjsports-2023-107625 · Cited by 26
Revolutionizing bone defect healing: the power of mesenchymal stem cells as seeds
Zhang, Y., Fan, M., & Zhang, Y. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1421674 · Cited by 24
“A systematic review and meta-analysis con fi rmed that MSCs therapy signi fi cantly augmented the progress of bone regeneration and signi fi cantly reduced the incidence of poor recovery (Yi et al., 2022).”
BackgroundNasadiuk, K., Kolanowski, T. J., Kowaléwski, C., Woźniak, K., Ołdak, T., & Rozwadowska, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010199 · Cited by 16
“Clinically, MSC’s application was shown to be characterized by a significantly reduced incidence of poor recovery, and patients with bone fractures were reported to benefit from MSCs administration although larger randomized clinical trials are necessary to confirm these findings [64].”
Metadata
- Authors
- Yi, H., Wang, Y., Liang, Q., & Mao, X.
- Affiliations
- Sun Yat-sen University (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Corresponding author
- Yi, Hanxiao
- Mao, Xiaoqun
- Venue
- Cell Transplantation
- Publisher
- SAGE Publications
- Published
- 2022-01-01
- Volume
- 31
- Pages
- 9636897211051743-9636897211051743
- ISSN
- 0963-6897 (ISSN-L)
- 1555-3892
- PMC
- PMC9350497
- OpenAlex
- W4289537149
- Cited by
- 18
- References
- 52
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 9 · 2023: 2
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cell Transplantation (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Nurturing funds for nursing young talents of Sun Yat-sen University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Keywords
- mesenchymal stem cells, bone fractures, fracture healing, bone regeneration, bone strength, healing time, cell therapy
- MeSH terms
- Bone and Bones, Bone Regeneration, Humans, Fractures, Bone, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preclinical and Clinical Amelioration of Bone Fractures with Mesenchymal Stromal Cells: a Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1177/09636897211051743
- The paper
- Yi, H., Wang, Y., Liang, Q., & Mao, X. (2022). Preclinical and Clinical Amelioration of Bone Fractures with Mesenchymal Stromal Cells: a Systematic Review and Meta-Analysis. Cell Transplantation. https://doi.org/10.1177/09636897211051743
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.